1 | A bill to be entitled |
2 | An act relating to a Medicaid utilization management |
3 | program; amending s. 409.912, F.S.; deleting a provision |
4 | that requires the Agency for Health Care Administration to |
5 | develop and implement a utilization management program for |
6 | Medicaid-eligible recipients for the management of |
7 | occupational, physical, respiratory, and speech therapies; |
8 | amending s. 409.91211, F.S.; conforming a cross-reference; |
9 | providing an effective date. |
10 |
|
11 | Be It Enacted by the Legislature of the State of Florida: |
12 |
|
13 | Section 1. Subsections (43) through (52) of section |
14 | 409.912, Florida Statutes, are renumbered as subsections (42) |
15 | through (51), respectively, and present subsection (42) of that |
16 | section is amended to read: |
17 | 409.912 Cost-effective purchasing of health care.--The |
18 | agency shall purchase goods and services for Medicaid recipients |
19 | in the most cost-effective manner consistent with the delivery |
20 | of quality medical care. To ensure that medical services are |
21 | effectively utilized, the agency may, in any case, require a |
22 | confirmation or second physician's opinion of the correct |
23 | diagnosis for purposes of authorizing future services under the |
24 | Medicaid program. This section does not restrict access to |
25 | emergency services or poststabilization care services as defined |
26 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
27 | shall be rendered in a manner approved by the agency. The agency |
28 | shall maximize the use of prepaid per capita and prepaid |
29 | aggregate fixed-sum basis services when appropriate and other |
30 | alternative service delivery and reimbursement methodologies, |
31 | including competitive bidding pursuant to s. 287.057, designed |
32 | to facilitate the cost-effective purchase of a case-managed |
33 | continuum of care. The agency shall also require providers to |
34 | minimize the exposure of recipients to the need for acute |
35 | inpatient, custodial, and other institutional care and the |
36 | inappropriate or unnecessary use of high-cost services. The |
37 | agency shall contract with a vendor to monitor and evaluate the |
38 | clinical practice patterns of providers in order to identify |
39 | trends that are outside the normal practice patterns of a |
40 | provider's professional peers or the national guidelines of a |
41 | provider's professional association. The vendor must be able to |
42 | provide information and counseling to a provider whose practice |
43 | patterns are outside the norms, in consultation with the agency, |
44 | to improve patient care and reduce inappropriate utilization. |
45 | The agency may mandate prior authorization, drug therapy |
46 | management, or disease management participation for certain |
47 | populations of Medicaid beneficiaries, certain drug classes, or |
48 | particular drugs to prevent fraud, abuse, overuse, and possible |
49 | dangerous drug interactions. The Pharmaceutical and Therapeutics |
50 | Committee shall make recommendations to the agency on drugs for |
51 | which prior authorization is required. The agency shall inform |
52 | the Pharmaceutical and Therapeutics Committee of its decisions |
53 | regarding drugs subject to prior authorization. The agency is |
54 | authorized to limit the entities it contracts with or enrolls as |
55 | Medicaid providers by developing a provider network through |
56 | provider credentialing. The agency may competitively bid single- |
57 | source-provider contracts if procurement of goods or services |
58 | results in demonstrated cost savings to the state without |
59 | limiting access to care. The agency may limit its network based |
60 | on the assessment of beneficiary access to care, provider |
61 | availability, provider quality standards, time and distance |
62 | standards for access to care, the cultural competence of the |
63 | provider network, demographic characteristics of Medicaid |
64 | beneficiaries, practice and provider-to-beneficiary standards, |
65 | appointment wait times, beneficiary use of services, provider |
66 | turnover, provider profiling, provider licensure history, |
67 | previous program integrity investigations and findings, peer |
68 | review, provider Medicaid policy and billing compliance records, |
69 | clinical and medical record audits, and other factors. Providers |
70 | shall not be entitled to enrollment in the Medicaid provider |
71 | network. The agency shall determine instances in which allowing |
72 | Medicaid beneficiaries to purchase durable medical equipment and |
73 | other goods is less expensive to the Medicaid program than long- |
74 | term rental of the equipment or goods. The agency may establish |
75 | rules to facilitate purchases in lieu of long-term rentals in |
76 | order to protect against fraud and abuse in the Medicaid program |
77 | as defined in s. 409.913. The agency may seek federal waivers |
78 | necessary to administer these policies. |
79 | (42) The agency shall develop and implement a utilization |
80 | management program for Medicaid-eligible recipients for the |
81 | management of occupational, physical, respiratory, and speech |
82 | therapies. The agency shall establish a utilization program that |
83 | may require prior authorization in order to ensure medically |
84 | necessary and cost-effective treatments. The program shall be |
85 | operated in accordance with a federally approved waiver program |
86 | or state plan amendment. The agency may seek a federal waiver or |
87 | state plan amendment to implement this program. The agency may |
88 | also competitively procure these services from an outside vendor |
89 | on a regional or statewide basis. |
90 | Section 2. Paragraph (e) of subsection (3) of section |
91 | 409.91211, Florida Statutes, is amended to read: |
92 | 409.91211 Medicaid managed care pilot program.-- |
93 | (3) The agency shall have the following powers, duties, |
94 | and responsibilities with respect to the pilot program: |
95 | (e) To implement policies and guidelines for phasing in |
96 | financial risk for approved provider service networks over a 3- |
97 | year period. These policies and guidelines must include an |
98 | option for a provider service network to be paid fee-for-service |
99 | rates. For any provider service network established in a managed |
100 | care pilot area, the option to be paid fee-for-service rates |
101 | shall include a savings-settlement mechanism that is consistent |
102 | with s. 409.912(43)(44). This model shall be converted to a |
103 | risk-adjusted capitated rate no later than the beginning of the |
104 | fourth year of operation, and may be converted earlier at the |
105 | option of the provider service network. Federally qualified |
106 | health centers may be offered an opportunity to accept or |
107 | decline a contract to participate in any provider network for |
108 | prepaid primary care services. |
109 | Section 3. This act shall take effect July 1, 2008. |